Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sandra Torres-Ruiz"'
Autor:
Sandra Torres-Ruiz, Iris Garrido-Cano, Ana Lameirinhas, Octavio Burgués, Cristina Hernando, María Teresa Martínez, Federico Rojo, Begoña Bermejo, Marta Tapia, Juan Antonio Carbonell-Asins, Carlos Javier Peña, Ana Lluch, Juan Miguel Cejalvo, Eduardo Tormo, Pilar Eroles
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-13 (2024)
Abstract Despite progress in breast cancer treatment, a significant portion of patients still relapse because of drug resistance. The involvement of microRNAs in cancer progression and chemotherapy response is well established. Therefore, this study
Externí odkaz:
https://doaj.org/article/3a1b2fe95e2d47d181a620741b4f85f7
Autor:
Iris Garrido-Cano, Pilar Eroles, Birlipta Pattanayak, Raimundo Cervera, Ana Lameirinhas, Sandra Torres-Ruiz, Eduardo Tormo, Anna Adam-Artigues
Publikováno v:
Cancer and Metastasis Reviews. 41:77-105
Breast cancer is the most frequent cancer in women worldwide. Despite the improvement in diagnosis and treatments, the rates of cancer relapse and resistance to therapies remain higher than desirable. Alterations in microRNAs have been linked to chan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2efc685c770470709d306586da48b175
https://doi.org/10.1007/s10555-021-09992-0
https://doi.org/10.1007/s10555-021-09992-0
Autor:
Birlipta Pattanayak, Ana Lameirinhas, Sandra Torres-Ruiz, Octavio Burgués, Ana Rovira, María Teresa Martínez, Marta Tapia, Sandra Zazo, Joan Albanell, Federico Rojo, Begoña Bermejo, Pilar Eroles
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 21; Pages: 13292
Treatment for the HER2+ breast cancer subtype is still unsatisfactory, despite breakthroughs in research. The discovery of various new molecular mechanisms of transcription factors may help to make treatment regimens more effective. The transcription
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db9be6c0a644149b69aa59aacd92c2f
Autor:
Paula Cabello, Sandra Torres-Ruiz, Anna Adam-Artigues, Jaume Forés-Martos, María Teresa Martínez, Cristina Hernando, Sandra Zazo, Juan Madoz-Gúrpide, Ana Rovira, Octavio Burgués, Federico Rojo, Joan Albanell, Ana Lluch, Begoña Bermejo, Juan Miguel Cejalvo, Pilar Eroles
Publikováno v:
Cancers; Volume 15; Issue 7; Pages: 2138
Trastuzumab treatment has significantly improved the prognosis of HER2-positive breast cancer patients. Despite this, resistance to therapy still remains the main clinical challenge. In order to evaluate the implication of microRNAs in the trastuzuma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c17f0f958e9898f8597214c05cc99fc7
https://doi.org/10.3390/cancers15072138
https://doi.org/10.3390/cancers15072138
Autor:
Sandra Torres-Ruiz, Eduardo Tormo, Iris Garrido-Cano, Ana Lameirinhas, Federico Rojo, Juan Madoz-Gúrpide, Octavio Burgués, Cristina Hernando, Begoña Bermejo, María Teresa Martínez, Ana Lluch, Juan Miguel Cejalvo, Pilar Eroles
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 4
Pages: 3601
Volume 24
Issue 4
Pages: 3601
Due to the lack of specific targets, cytotoxic chemotherapy still represents the common standard treatment for triple-negative breast patients. Despite the harmful effect of chemotherapy on tumor cells, there is evidence that treatment could modulate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeac56db856fe1cc6ed911ea87feb8f7
https://doi.org/10.3390/ijms24043601
https://doi.org/10.3390/ijms24043601